Saluja et al. published their findings of a TCV co-administered with MMR and showed that the seropositivity levels for anti-measles, anti-mumps, and anti-rubella were similar in their MMR-only and MMR plus TCV co-administration arms [13]. The gene discussed is MRC1; the disease is rubella.